Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Concomitant LAAC/AF Ablation (Watchman FLX Pro)

NCT: NCT07041125 · COMPLETED

NCT IDNCT07041125
StatusCOMPLETED
Start Date2025-06-01
Completion2026-06-30
SponsorHeart Rhythm Clinical and Research Solutions, LLC (OTHER)
First posted
Last updated

Brief Summary

This sub-study is a prospective/retrospective, non-randomized, observational, comparative cohorts study, embedded in and expanding on the infrastructure of a real-world AF ablation registry DISRUPT-AF (NCT06335082).

Frequently Asked Questions

What is Concomitant LAAC/AF Ablation (Watchman FLX Pro)?

Concomitant LAAC/AF Ablation (Watchman FLX Pro) is a clinical trial registered under NCT07041125. Current status: COMPLETED.

What is the status of NCT07041125?

The current status of NCT07041125 (Concomitant LAAC/AF Ablation (Watchman FLX Pro)) is: COMPLETED.

When did Concomitant LAAC/AF Ablation (Watchman FLX Pro) start?

Concomitant LAAC/AF Ablation (Watchman FLX Pro) started on 2025-06-01.

Related Devices

K190884TigerPaw Pro Left Atrial Appendage Occlusion Fastener And Delivery ToolDatascope Corp.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑